Oral Cavity Neoplasma

Embed Size (px)

Citation preview

  • 7/30/2019 Oral Cavity Neoplasma

    1/42

    NEOPLASMS OF THE

    ORAL CAVITY

    Divisi Onkologi

  • 7/30/2019 Oral Cavity Neoplasma

    2/42

    ANATOMY

    Lips to the junctional of hard and soft pallate

    Mucosa buccal

    Upper and lower alveolar bridges

    Retromollar trigone 2/3 oral tongue

    Floor mouth

    Hard palate

  • 7/30/2019 Oral Cavity Neoplasma

    3/42

  • 7/30/2019 Oral Cavity Neoplasma

    4/42

    EPIDEMIOLOGI

    Risk factor alcohol, tobacco

    95% Ca sel skuamosa

    Pria : Wanita = 1:2

    95% > 40 tahun; umur rata-rata 60 tahun the human papillomavirus (HPV) may play a role in

    the etiology of oral cavity

  • 7/30/2019 Oral Cavity Neoplasma

    5/42

  • 7/30/2019 Oral Cavity Neoplasma

    6/42

  • 7/30/2019 Oral Cavity Neoplasma

    7/42

  • 7/30/2019 Oral Cavity Neoplasma

    8/42

  • 7/30/2019 Oral Cavity Neoplasma

    9/42

    Lesi mukosa putih ataupun merah membutuhkan biopsi

    Lesi leukoplakia benigna dan tidak menghilang setelah

    menghentikan tobako, pengobatan masih tidak jelas.

    Surgical excision, laser excision, and similar techniques have all

    been used with some degree of success. Nonsurgical

    approaches, such as topical vitamin A therapy, also have been

    tried, with complete response rates in the 10% to 27% range

    and partial response rates in 54% to 90% of patients.

    The side effects were minimal, but leukoplakia recurred in 50%

    of patients after discontinuation of the medication

  • 7/30/2019 Oral Cavity Neoplasma

    10/42

  • 7/30/2019 Oral Cavity Neoplasma

    11/42

    RADIATION THERAPY

    Radiation therapy and surgery have equal success in controlling T1

    lesions of the oral cavity.

    Treatment options must be determined by numerous factors, including

    the location, the patient's physical condition and social and economic

    situation, and the experience of those delivering the care.

    Radiation therapy tends to provide a better functional result with superior

    speech and swallowing, but significant disadvantages of radiation

    therapy are diminution of taste, xerostomia, and the protracted nature ofthe treatment course.

    Unlike surgery, a curative dosage of radiation therapy requires at least 6

    weeks of treatment, and this can affect the treatment choice.

    When considering oral cavity cancers, the highest rate of complicationsrelated to external beam radiation occurs in patients with floor-of-mouth

    cancer; historically, in one fourth or more of these patients,

    osteoradionecrosis of the mandible developed.

    Newer techniques brachytherapy and intensity-modulated radiation

    therapy (IMRT) more focused targeting and reduced complications

  • 7/30/2019 Oral Cavity Neoplasma

    12/42

    CHEMOTHERAPY

    Although the combination of radiation therapy and

    surgery provides a better chance for cure for stage

    III and IV disease than does either modality alone,

    substantial evidence suggests that the addition of

    concomitant chemotherapy to postoperative

    radiation therapy improves locoregional control andsurvival in these patients

  • 7/30/2019 Oral Cavity Neoplasma

    13/42

    BUCCAL CARCINOMA

    uncommon cancer

    Buccal carcinomas occur most commonly in 70-year-oldmen and are found in a region of cheek leukoplakia.

    The exophytic lesions may have a relatively benign

    appearance and may not penetrate into the soft tissues

    of the cheek until they are relatively large. The ulcerative lesions, however, penetrate early and

    make cure more difficult because of their involvement of

    adjacent muscle, bone, and skin

    Because no natural barriers to tumor penetration exist inthe cheek, cure rates are not as good as one might

    expect in a region so easily inspected.

  • 7/30/2019 Oral Cavity Neoplasma

    14/42

    As with most oral cavity neoplasms, T1 lesions can be treated either

    with surgery or radiation therapy, although resection and coverage of

    the area with a split-thickness skin graft may be more convenient and

    expedient.

    Because T1 lesions are rare, large series comparing treatmentmodalities cannot be found. Three-year survival rates for T1 and T2

    lesions are approximately 80% and 60%, respectively, and

    depending on the extent of the lesions, marginal or rim

    mandibulectomy or partial maxillectomy or both may be necessary

    for adequate margins Surgery plus radiation therapy is the treatment of choice for stage III

    and IV disease. The extent of resection of these larger lesions is

    variable, but may include resection of the maxilla or mandible,

    parotidectomy, neck dissection, or a combination of these.

    Reconstruction is with free (radial forearm) or regional myocutaneous(temporalis, pectoralis major) flaps or with an osteomyocutaneous

    free flap if bone is needed.

  • 7/30/2019 Oral Cavity Neoplasma

    15/42

    HARD PALATUM CARCINOMA

    Primary malignancies of the hard palate are uncommon

    with a relatively equal incidence of squamous cell

    carcinoma and salivary gland malignancies.

    Because nodal metastases are retropharyngeal, it is

    unnecessary to be concerned with prophylactic necktherapy.

    Only those patients with T4 lesions begin to approach

    an incidence of nodal metastases (25%) for which

    prophylactic neck irradiation would be considered.

    Although distant metastases are rare with squamous

    cell carcinoma of the hard palate, an incidence of 12%

    has been found in patients with salivary gland tumors

  • 7/30/2019 Oral Cavity Neoplasma

    16/42

    Radiation therapy has been reported to be as effective as

    surgery in treating T1 and T2 lesions, for those of both

    salivary gland and squamous etiology.

    It is probably true, however, that T1 lesions are most

    easily treated by excision.

    For the larger T3 and T4 lesions (the 5-year survival rate

    decreases from 85% for a T1 lesion to 30% for a T4

    lesion), the treatment of choice is a combination of

    surgery and radiation therapy

    Partial or total maxillectomy is often required, and the

    traditional reconstruction has been with a prosthetic

    obturator, requiring preoperative evaluation by aprosthodontist

  • 7/30/2019 Oral Cavity Neoplasma

    17/42

    ORAL TONGUE

    In deciding on treatment modalities for oral tongue

    cancer, the same factors are applicable as for most otherhead and neck sites.

    T1-2 lesions can be treated by surgery or radiationtherapy, and T3-4 lesions do best with combinationtherapy.

    Radiation treatment alone achieves control rates of 86%for T1 and 75% for T2 lesions.

    Because of the high complication rate associated withcurative doses suggested a policy of initial surgery, with

    postoperative radiation therapy being reserved forpatients with a suspected high rate of local or neckfailure.

  • 7/30/2019 Oral Cavity Neoplasma

    18/42

  • 7/30/2019 Oral Cavity Neoplasma

    19/42

  • 7/30/2019 Oral Cavity Neoplasma

    20/42

  • 7/30/2019 Oral Cavity Neoplasma

    21/42

  • 7/30/2019 Oral Cavity Neoplasma

    22/42

  • 7/30/2019 Oral Cavity Neoplasma

    23/42

    1. The incisive foramina house the

    A. Greater palatine vessels and nerves

    B. Sphenopalatine nerve

    C. Palatine nerves and nasopalatine arteries

    D. Anterior and posterior superior alveolar nerves

    E. Lesser palatine nerve

  • 7/30/2019 Oral Cavity Neoplasma

    24/42

    C

  • 7/30/2019 Oral Cavity Neoplasma

    25/42

    2. A benign oral cavity lession sometimes mistaken

    pathologically for squamous cell carcinoma is

    a. Squamous papilloma

    b. Granular cell myoblastomac. leukoplakia

    d. fibrous histiocytoma

    e. erythroplakia

  • 7/30/2019 Oral Cavity Neoplasma

    26/42

    B

  • 7/30/2019 Oral Cavity Neoplasma

    27/42

    3. Of oral cavity cancers treated primarily with

    radiotherapy for cure, the site treated with the

    highest complication rate is the

    a. Floor of mouth

    b. Tongue

    c. buccal mucosa

    d. Anterior tonsillar pillar

    e. Retromolar trigone

  • 7/30/2019 Oral Cavity Neoplasma

    28/42

    A

  • 7/30/2019 Oral Cavity Neoplasma

    29/42

    4. Due to lack of natural barriers in the cheek, buccal

    carcinomas, with the following thickness have a

    batter prognosis

    a. Less than 10 mm

    b. Less than 6 mm

    c. between 10 and 12 mm

    d. Greater than 6 mm

    e. Less than or equal to 15 mm

  • 7/30/2019 Oral Cavity Neoplasma

    30/42

    B

  • 7/30/2019 Oral Cavity Neoplasma

    31/42

    5. Primary malignancies of which oral cavity site are

    equally distributed between salivary gland and

    squamous cell carcinoma

    a. Floor of mouth

    b. Anterior tonsillar pillar

    c. hard palate

    d. Tongue

    e. Buccal mucosa

  • 7/30/2019 Oral Cavity Neoplasma

    32/42

    C

  • 7/30/2019 Oral Cavity Neoplasma

    33/42

    6. Alveolus carcinomas are most commonly located

    in the

    a. Anterior maxillary segment

    b. Posterior third of the mandible

    c. anterior mandibular arch

    d. Body of mandible

    e. Posterior alveolus

  • 7/30/2019 Oral Cavity Neoplasma

    34/42

    B

  • 7/30/2019 Oral Cavity Neoplasma

    35/42

  • 7/30/2019 Oral Cavity Neoplasma

    36/42

  • 7/30/2019 Oral Cavity Neoplasma

    37/42

  • 7/30/2019 Oral Cavity Neoplasma

    38/42

    C

  • 7/30/2019 Oral Cavity Neoplasma

    39/42

    9. The most common surgical reconstructive

    technique for the resurfacing of oral cavity defects

    after oncologic resection is

    a. Full-thickness skin graft

    b. Split-thickness skin graft

    c. radial forearm free flap

    d. Tongue flap

    e. Myocutaneous flap

  • 7/30/2019 Oral Cavity Neoplasma

    40/42

    B

  • 7/30/2019 Oral Cavity Neoplasma

    41/42

  • 7/30/2019 Oral Cavity Neoplasma

    42/42

    D